Revolution MD Patents Biometric Smart Inhaler for Opioid Oversight
Revolution MD has secured a US patent for a biometric-authenticated smart inhaler platform for controlled substances such as opioids, with AI-driven oversight.
Articles tagged with Controlled Substances
Revolution MD has secured a US patent for a biometric-authenticated smart inhaler platform for controlled substances such as opioids, with AI-driven oversight.
Electronic prescribing, or e-prescribing, is revolutionizing healthcare by enabling clinicians to send prescriptions directly to pharmacies, improving…
“MedixSafe and SPT both have a significant installation base with EMS & Fire agencies and those customers will benefit from the unification under BioConnect’s…